Bolt Biotherapeutics, Inc.
BOLT • NASDAQ
Bolt Biotherapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO William Quinn, with a market cap of $8.4M.
Market Cap$8.4M
Employees100.0
CEOWilliam Quinn
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Bolt Biotherapeutics, Inc. FAQ
Common questions about Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $1.5M.
Bolt Biotherapeutics, Inc. has approximately 100 employees.